广州誉衡生物科技有限公司
Location: China
Employees: 201-500
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | 6 Dimensio... | 6dimension... |
Mentions in press and media 1
| Date | Title | Description |
| 06.09.2023 | Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer | The first and only anti-PD-1 antibody approved for treating cervical cancer in China ORR of 27.8%, mPFS of 3.7m, and mOS of 16.8m achieved as monotherapy with best-in-class potential A Phase 3 trial (VICT-004) of zimberelimab in combination... |